HEXB and Sandhoff disease: Intracerebroventricular (ICV) injections of a modified HexB, with both HexA and HexB activities, into Sandhoff’s disease mouse models showed marked reductions in GM2 and a two-fold increase in Hex activity, as well as an observed reduction of GM2 in the liver (Matsuoka et al., 2011).